Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Laureate Pharma to supply Enobia with sPHEX metallopeptidase for phase I trials

Sep. 27, 2005

SHEPHERD study of eculizumab for PNH completes enrollment

Sep. 27, 2005

Inhibition of MMPs may emerge as an antidiabetic strategy

Sep. 27, 2005

Studies reveal efficacy of Lanreotide Autogel in acromegaly patients

Sep. 26, 2005

Triglyceride reducing agents emerge from Esteve R&D

Sep. 26, 2005

Ruboxistaurin improves renal function in patients with type 2 diabetes and nephropathy

Sep. 26, 2005

Farnesyltransferase inhibitors show promise for treating progeria

Sep. 26, 2005

Anti-HEH4 antibodies claimed for bone or cartilage-related disorders

Sep. 22, 2005

Novel antidiabetic agents disclosed in recent patent literature

Sep. 22, 2005

Isis begins phase II development of second-generation antisense drug for high cholesterol

Sep. 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...